Cargando…
Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study
Acute lymphoblastic leukemia (ALL) is a cancer-specific lymphoid cell. Induction and consolidation chemotherapy alone or in combination with different therapeutic approaches remain the main treatment. Although complete or partial remission of the disease can be achieved, the risk of relapse or refra...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395272/ https://www.ncbi.nlm.nih.gov/pubmed/34987176 http://dx.doi.org/10.1038/s41417-021-00418-1 |